 "Alembic Pharmaceuticals ups its US game plan, acquires Orit")
Alembic Pharmaceuticals Limited (APL) has seen its consolidated profit before tax (PBT) grow by 91.40 per cent before exceptional items for the first quarter ended June 30, 2020 of financial year 2020-21. As against a consolidated PBT of Rs 187.82 crore in the corresponding Q1 in FY20, the same grew to Rs 359.50 crore in Q1 of FY21.
The company's consolidated total income rose by 40.89 per cent to stand at Rs 1,341.64 crore in Q1 of FY21 as compared to Rs 952.20 crore in Q1 of FY20.
According to Pranav Amin, Managing Director, Alembic Pharmaceuticals Limited, despite challenging circumstances due to
